{"id":988735,"date":"2026-08-03T16:09:30","date_gmt":"2026-08-03T20:09:30","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/"},"modified":"2026-08-03T16:09:30","modified_gmt":"2026-08-03T20:09:30","slug":"promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/","title":{"rendered":"ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026"},"content":{"rendered":"
\n

\n Company to host investor conference call and webcast at 4:30 p.m. ET.<\/em>\n <\/p>\n

\n Cambridge, Massachusetts, Aug. 03, 2026 (GLOBE NEWSWIRE) — <\/strong>ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced it will report financial results for the second quarter ended June 30, 2026, and provide corporate updates on August 13, 2026.<\/p>\n

The company will host a conference call and webcast on the same day of August 13, 2026 at 4:30 p.m. ET.<\/p>\n

\n
\n Conference Call and Webcast Information:\u00a0<\/u>
\n <\/strong>\n <\/p>\n\n\n\n\n\n\n\n
\n \u00a0 Date:<\/strong>\n <\/td>\nAugust 13, 2026<\/td>\n<\/tr>\n
\n \u00a0 Time:<\/strong>\n <\/td>\n4:30 p.m. Eastern Time<\/td>\n<\/tr>\n
\n \u00a0 Dial-in:<\/strong>\n <\/td>\n1-877-407-9208 (U.S. Investors)
1-201-493-6784 (International)<\/td>\n<\/tr>\n
\n \u00a0 Conference I.D.:<\/strong>\n <\/td>\n13761812<\/td>\n<\/tr>\n
\n \u00a0 CallMe<\/strong>
\n
\n TM<\/strong>
\n <\/sup>
\n :<\/strong>\n <\/td>\n		\n
\n Click Here<\/u>
\n <\/a>\n <\/td>\n<\/tr>\n
\n \u00a0 Webcast:<\/strong>\n <\/td>\n\n
\n Click Here<\/u>
\n <\/a>\n <\/td>\n<\/tr>\n<\/table>\n

A replay of the webcast will be available in the Investors section of the ProMIS website following the completion of the call.<\/p>\n

\n About ProMIS Neurosciences Inc.<\/strong>
\n
ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies and vaccines selective for toxic oligomers associated with the development and progression of neurodegenerative and other misfolded protein diseases. The Company’s proprietary target discovery engine, EpiSelect\u2122, has been shown to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins that cause neurodegenerative diseases, including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), multiple system atrophy (MSA), and Parkinson’s disease (PD). ProMIS has offices in Cambridge, Massachusetts (USA) and Toronto, Ontario (CAN).<\/p>\n

\n For further information:<\/strong>
\n
Visit us at www.promisneurosciences.com<\/p>\n

\n Media Contact<\/strong>
\n
Maggie Whitney
LifeSci Communications
mwhitney@lifescicomms.com<\/p>\n

\n Investor Relations Contact<\/strong>
\n
Carie Pierce
VP Investor Relations & External Affairs
IR@ProMISNeurosciences.com<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Company to host investor conference call and webcast at 4:30 p.m. ET. Cambridge, Massachusetts, Aug. 03, 2026 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced it will report financial results for the second quarter ended June 30, 2026, and provide corporate updates on August 13, 2026. The company will host a conference call and webcast on the same day of August 13, 2026 at 4:30 p.m. ET. Conference Call and Webcast Information:\u00a0 \u00a0 Date: August 13, 2026 \u00a0 Time: 4:30 p.m. Eastern Time \u00a0 Dial-in: 1-877-407-9208 (U.S. Investors)1-201-493-6784 (International) \u00a0 Conference I.D.: 13761812 \u00a0 CallMe TM : Click Here \u00a0 Webcast: Click … <\/p>\n

Continue reading “ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-988735","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Company to host investor conference call and webcast at 4:30 p.m. ET. Cambridge, Massachusetts, Aug. 03, 2026 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced it will report financial results for the second quarter ended June 30, 2026, and provide corporate updates on August 13, 2026. The company will host a conference call and webcast on the same day of August 13, 2026 at 4:30 p.m. ET. Conference Call and Webcast Information:\u00a0 \u00a0 Date: August 13, 2026 \u00a0 Time: 4:30 p.m. Eastern Time \u00a0 Dial-in: 1-877-407-9208 (U.S. Investors)1-201-493-6784 (International) \u00a0 Conference I.D.: 13761812 \u00a0 CallMe TM : Click Here \u00a0 Webcast: Click … Continue reading "ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-03T20:09:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMjYyNCM3NzU2MDEzIzIwODQ1ODk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026\",\"datePublished\":\"2026-08-03T20:09:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\\\/\"},\"wordCount\":273,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMjYyNCM3NzU2MDEzIzIwODQ1ODk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\\\/\",\"name\":\"ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMjYyNCM3NzU2MDEzIzIwODQ1ODk=\",\"datePublished\":\"2026-08-03T20:09:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMjYyNCM3NzU2MDEzIzIwODQ1ODk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMjYyNCM3NzU2MDEzIzIwODQ1ODk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/","og_locale":"en_US","og_type":"article","og_title":"ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026 - Market Newsdesk","og_description":"Company to host investor conference call and webcast at 4:30 p.m. ET. Cambridge, Massachusetts, Aug. 03, 2026 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced it will report financial results for the second quarter ended June 30, 2026, and provide corporate updates on August 13, 2026. The company will host a conference call and webcast on the same day of August 13, 2026 at 4:30 p.m. ET. Conference Call and Webcast Information:\u00a0 \u00a0 Date: August 13, 2026 \u00a0 Time: 4:30 p.m. Eastern Time \u00a0 Dial-in: 1-877-407-9208 (U.S. Investors)1-201-493-6784 (International) \u00a0 Conference I.D.: 13761812 \u00a0 CallMe TM : Click Here \u00a0 Webcast: Click … Continue reading \"ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-03T20:09:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMjYyNCM3NzU2MDEzIzIwODQ1ODk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026","datePublished":"2026-08-03T20:09:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/"},"wordCount":273,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMjYyNCM3NzU2MDEzIzIwODQ1ODk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/","name":"ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMjYyNCM3NzU2MDEzIzIwODQ1ODk=","datePublished":"2026-08-03T20:09:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMjYyNCM3NzU2MDEzIzIwODQ1ODk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMjYyNCM3NzU2MDEzIzIwODQ1ODk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/promis-neurosciences-to-report-second-quarter-2026-financial-results-and-business-update-on-august-13-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/988735","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=988735"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/988735\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=988735"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=988735"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=988735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}